Premium
Patient survival factors in paranasal sinus mucormycosis
Author(s) -
Blitzer Andrew,
Lawson William,
Meyers Bert R.,
Biller Hugh F.
Publication year - 1980
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1288/00005537-198004000-00010
Subject(s) - medicine , mucormycosis , sinus (botany) , surgery , paranasal sinuses , deformity , debridement (dental) , disease , amphotericin b , survival rate , dermatology , antifungal , botany , biology , genus
Analysis of 170 cases of paranasal sinus mucormycosis collected from the literature and 9 cases of our own revealed a 50% mortality for this disease. When analyzed according to decade, survival has increased to 70% in the cases reported from 1970‐1979. There were no significant differences between the survivors and the fatalities when evaluated according to age, sex, laterality, or radiographic findings. There was a markedly poorer prognosis for those patients with hemiplegia, facial necrosis, and nasal deformity. The underlying disease was an important determinant of survival: 75% of patients with no systemic disease, 60% of diabetics, and 20% of patients with other disorders survived. Surgical debridement or radical resection and the use of amphotericin B significantly increased survival. Their combination further enhanced survival, especially in the diabetic.